J
JSP Industrial Pharmacy (Thailand) PCL
SET:JSP
JSP Industrial Pharmacy (Thailand) PCL
SET:JSP
Price:
1.95
THB
1.04%
Market Closed
Market Cap:
฿925.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
J
|
JSP Industrial Pharmacy (Thailand) PCL
SET:JSP
|
TH |
|
Linc Ltd
NSE:LINC
|
IN |
|
A
|
Akola Group AB
XMUN:YG4
|
LT |
|
T
|
TriSalus Life Sciences Inc
NASDAQ:TLSI
|
US |
|
Calloway's Nursery Inc
OTC:CLWY
|
US |
|
111 Inc
NASDAQ:YI
|
CN |
|
Hindustan Aeronautics Ltd
NSE:HAL
|
IN |
|
Exela Technologies Inc
NASDAQ:XELA
|
US |
|
S
|
Sierra Rutile Holdings Ltd
ASX:SRX
|
AU |
|
S
|
SMC Global Securities Ltd
NSE:SMCGLOBAL
|
IN |
Income Statement
Earnings Waterfall
JSP Industrial Pharmacy (Thailand) PCL
JSP Industrial Pharmacy (Thailand) PCL
Income Statement
JSP Industrial Pharmacy (Thailand) PCL
JSP Industrial Pharmacy (Thailand) PCL
Currency: THB
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Interest Expense |
11
|
8
|
8
|
8
|
10
|
10
|
9
|
8
|
7
|
7
|
9
|
11
|
13
|
15
|
16
|
17
|
17
|
0
|
0
|
0
|
0
|
|
| Revenue |
456
N/A
|
427
-6%
|
417
-2%
|
416
0%
|
422
+2%
|
411
-3%
|
397
-3%
|
399
+0%
|
429
+8%
|
465
+9%
|
487
+5%
|
554
+14%
|
576
+4%
|
607
+5%
|
685
+13%
|
742
+8%
|
824
+11%
|
897
+9%
|
960
+7%
|
993
+3%
|
1 010
+2%
|
|
| Gross Profit | ||||||||||||||||||||||
| Cost of Revenue |
(310)
|
(285)
|
(273)
|
(274)
|
(278)
|
(277)
|
(282)
|
(284)
|
(306)
|
(331)
|
(354)
|
(410)
|
(432)
|
(456)
|
(484)
|
(492)
|
(519)
|
(545)
|
(570)
|
(589)
|
(605)
|
|
| Gross Profit |
146
N/A
|
142
-3%
|
144
+1%
|
142
-2%
|
144
+2%
|
134
-7%
|
115
-14%
|
115
0%
|
123
+7%
|
134
+9%
|
133
-1%
|
143
+8%
|
144
+0%
|
150
+5%
|
202
+34%
|
251
+24%
|
305
+22%
|
351
+15%
|
391
+11%
|
404
+3%
|
406
+0%
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(90)
|
(93)
|
(92)
|
(92)
|
(96)
|
(110)
|
(122)
|
(137)
|
(138)
|
(132)
|
(131)
|
(138)
|
(145)
|
(155)
|
(169)
|
(171)
|
(200)
|
(349)
|
(372)
|
(409)
|
(291)
|
|
| Selling, General & Administrative |
(94)
|
(97)
|
(94)
|
(96)
|
(99)
|
(118)
|
(132)
|
(145)
|
(140)
|
(143)
|
(141)
|
(149)
|
(163)
|
(172)
|
(185)
|
(197)
|
(221)
|
(254)
|
(280)
|
(307)
|
(323)
|
|
| Depreciation & Amortization |
(3)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
7
|
6
|
4
|
7
|
7
|
8
|
10
|
8
|
8
|
12
|
10
|
11
|
19
|
17
|
17
|
27
|
21
|
(94)
|
(92)
|
(102)
|
32
|
|
| Operating Income |
55
N/A
|
49
-12%
|
52
+7%
|
50
-4%
|
48
-3%
|
24
-51%
|
(7)
N/A
|
(23)
-231%
|
(15)
+33%
|
2
N/A
|
2
-29%
|
5
+241%
|
(1)
N/A
|
(5)
-338%
|
33
N/A
|
80
+141%
|
105
+31%
|
3
-97%
|
19
+611%
|
(5)
N/A
|
115
N/A
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
(11)
|
(11)
|
(10)
|
(11)
|
(10)
|
(9)
|
(9)
|
(7)
|
(7)
|
(7)
|
(8)
|
29
|
27
|
26
|
24
|
(17)
|
(20)
|
(17)
|
(18)
|
(18)
|
(18)
|
|
| Non-Reccuring Items |
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(116)
|
0
|
0
|
0
|
10
|
|
| Total Other Income |
(2)
|
(2)
|
(1)
|
1
|
(1)
|
(0)
|
0
|
0
|
1
|
0
|
0
|
10
|
11
|
9
|
7
|
(4)
|
(3)
|
(7)
|
(5)
|
(5)
|
(7)
|
|
| Pre-Tax Income |
40
N/A
|
36
-9%
|
41
+13%
|
40
-1%
|
37
-7%
|
14
-62%
|
(15)
N/A
|
(29)
-90%
|
(21)
+27%
|
(5)
+75%
|
(7)
-26%
|
44
N/A
|
36
-18%
|
31
-16%
|
64
+110%
|
59
-8%
|
(33)
N/A
|
(22)
+35%
|
(4)
+79%
|
(27)
-511%
|
100
N/A
|
|
| Net Income | ||||||||||||||||||||||
| Tax Provision |
(9)
|
(8)
|
(9)
|
(8)
|
(8)
|
(4)
|
2
|
5
|
4
|
1
|
2
|
(9)
|
(9)
|
(7)
|
(15)
|
(13)
|
0
|
(3)
|
(8)
|
(5)
|
(55)
|
|
| Income from Continuing Operations |
31
|
28
|
32
|
32
|
30
|
11
|
(13)
|
(24)
|
(18)
|
(4)
|
(5)
|
35
|
27
|
23
|
50
|
46
|
(33)
|
(25)
|
(12)
|
(32)
|
45
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
2
|
2
|
4
|
5
|
38
|
40
|
41
|
42
|
23
|
|
| Net Income (Common) |
31
N/A
|
28
-10%
|
32
+14%
|
32
+1%
|
30
-7%
|
11
-64%
|
(13)
N/A
|
(24)
-83%
|
(18)
+28%
|
(4)
+77%
|
(5)
-35%
|
3
N/A
|
(2)
N/A
|
(6)
-222%
|
22
N/A
|
51
+132%
|
5
-91%
|
14
+220%
|
28
+96%
|
10
-65%
|
68
+576%
|
|
| EPS (Diluted) |
0.07
N/A
|
0.07
N/A
|
0.08
+14%
|
0.08
N/A
|
0.08
N/A
|
0.03
-63%
|
-0.03
N/A
|
-0.06
-100%
|
-0.04
+33%
|
-0.02
+50%
|
-0.02
N/A
|
0
N/A
|
0
N/A
|
-0.01
N/A
|
0.05
N/A
|
0.11
+120%
|
0.01
-91%
|
0.03
+200%
|
0.06
+100%
|
0.02
-67%
|
0.14
+600%
|
|
Switch to:
Switch to:
See Also
Discover More
